Controlled study on the anxiolytic activity of a newly-developed benzodiazepine, metaclazepam.

@article{Marano1988ControlledSO,
  title={Controlled study on the anxiolytic activity of a newly-developed benzodiazepine, metaclazepam.},
  author={P Marano and Francesco Patti and Ferdinando Nicoletti},
  journal={Current medical research and opinion},
  year={1988},
  volume={11 1},
  pages={41-4}
}
A double-blind, parallel group study was carried out in 50 patients with an anxiety disorder to compare the anxiolytic efficacy and tolerability of a recently developed benzodiazepine, metaclazepam, with that of bromazepam. Patients were allocated at random to receive treatment for 2 weeks with either 15 mg metaclazepam or 4 mg bromazepam per day in two… CONTINUE READING